verapamil has been researched along with pentamidine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Coelho, AC; Cotrim, PC; Messier, N; Ouellette, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ang, CW; Avery, VM; Blaskovich, MAT; Butler, MS; Cooper, MA; Debnath, A; Hahn, HJ; Jarrad, AM; Jones, AJ; Karoli, T; Pelingon, R; Sykes, ML; Tan, L; West, NP; Woods, K | 1 |
| Kumar, M; Thakur, CP | 1 |
| Beverley, SM; Coelho, AC; Cotrim, PC | 1 |
| Aikawa, N; Suzuki, Y; Takaba, K | 1 |
1 review(s) available for verapamil and pentamidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for verapamil and pentamidine
| Article | Year |
|---|---|
Observations on the effect of verapamil with sodium stibogluconate in kala azar.
Topics: Administration, Oral; Adult; Antimony Sodium Gluconate; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Pentamidine; Splenomegaly; Verapamil | 1992 |
10 other study(ies) available for verapamil and pentamidine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes.
Topics: Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Cell Line; Drug Resistance; Humans; Leishmania; Macrophages; Monocytes; Parasitic Sensitivity Tests; Pentamidine; Protozoan Proteins; Recombinant Fusion Proteins | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
Topics: Animals; Antiparasitic Agents; Antitubercular Agents; Caco-2 Cells; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Entamoeba histolytica; Giardia lamblia; Humans; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Nitroimidazoles; Structure-Activity Relationship | 2018 |
Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major.
Topics: Amino Acid Sequence; Animals; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; DNA Transposable Elements; Drug Resistance; Gene Deletion; Genes, Protozoan; Genomic Library; Leishmania major; Molecular Sequence Data; Mutagenesis, Insertional; Pentamidine; Protein Structure, Tertiary; Protozoan Proteins; Restriction Mapping; Transformation, Genetic; Verapamil | 2003 |
A Simple Protocol for the Myocardial Differentiation of Human iPS Cells.
Topics: Activins; Bone Morphogenetic Protein 4; Calcium Channel Blockers; Carrier Proteins; Cell Differentiation; Cells, Cultured; Chromans; Embryoid Bodies; Homeobox Protein Nkx-2.5; Homeodomain Proteins; Humans; Induced Pluripotent Stem Cells; Myocardium; Pentamidine; Piperidines; Potassium Channel Blockers; Pyridines; Sulfonamides; Transcription Factors; Troponin T; Verapamil; Wnt3A Protein | 2015 |